These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 37373253)
21. Autoradiographical imaging of PPARgamma agonist effects on PBR/TSPO binding in TASTPM mice. Roberts JC; Friel SL; Roman S; Perren M; Harper A; Davis JB; Richardson JC; Virley D; Medhurst AD Exp Neurol; 2009 Apr; 216(2):459-70. PubMed ID: 19320004 [TBL] [Abstract][Full Text] [Related]
22. Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice. Dumont M; Stack C; Elipenahli C; Jainuddin S; Gerges M; Starkova N; Calingasan NY; Yang L; Tampellini D; Starkov AA; Chan RB; Di Paolo G; Pujol A; Beal MF Hum Mol Genet; 2012 Dec; 21(23):5091-105. PubMed ID: 22922230 [TBL] [Abstract][Full Text] [Related]
23. Visualization of brain amyloid and microglial activation in mouse models of Alzheimer's disease. Higuchi M Curr Alzheimer Res; 2009 Apr; 6(2):137-43. PubMed ID: 19355848 [TBL] [Abstract][Full Text] [Related]
24. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers. Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329 [TBL] [Abstract][Full Text] [Related]
25. Possible role of rice bran extract in microglial modulation through PPAR-gamma receptors in alzheimer's disease mice model. El-Din SS; Abd Elwahab S; Rashed L; Fayez S; Aboulhoda BE; Heikal OA; Galal AF; Nour ZA Metab Brain Dis; 2021 Oct; 36(7):1903-1915. PubMed ID: 34043126 [TBL] [Abstract][Full Text] [Related]
26. Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy. Sahara N; Maeda J; Ishikawa A; Tokunaga M; Suhara T; Higuchi M J Alzheimers Dis; 2018; 64(s1):S353-S359. PubMed ID: 29865054 [TBL] [Abstract][Full Text] [Related]
27. Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy. Selenica ML; Brownlow M; Jimenez JP; Lee DC; Pena G; Dickey CA; Gordon MN; Morgan D Neurodegener Dis; 2013; 11(4):165-81. PubMed ID: 22796753 [TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. Yan Q; Zhang J; Liu H; Babu-Khan S; Vassar R; Biere AL; Citron M; Landreth G J Neurosci; 2003 Aug; 23(20):7504-9. PubMed ID: 12930788 [TBL] [Abstract][Full Text] [Related]
30. Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology. Papadopoulos P; Rosa-Neto P; Rochford J; Hamel E PLoS One; 2013; 8(7):e68612. PubMed ID: 23874687 [TBL] [Abstract][Full Text] [Related]
31. Absence of microglia or presence of peripherally-derived macrophages does not affect tau pathology in young or old hTau mice. Zhu K; Pieber M; Han J; Blomgren K; Zhang XM; Harris RA; Lund H Glia; 2020 Jul; 68(7):1466-1478. PubMed ID: 32039516 [TBL] [Abstract][Full Text] [Related]
32. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Streit WJ; Braak H; Xue QS; Bechmann I Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731 [TBL] [Abstract][Full Text] [Related]
33. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology. Laversenne V; Nazeeruddin S; Källstig EC; Colin P; Voize C; Schneider BL Acta Neuropathol Commun; 2020 Nov; 8(1):198. PubMed ID: 33225991 [TBL] [Abstract][Full Text] [Related]
34. P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice. Ruan Z; Delpech JC; Venkatesan Kalavai S; Van Enoo AA; Hu J; Ikezu S; Ikezu T Mol Neurodegener; 2020 Aug; 15(1):47. PubMed ID: 32811520 [TBL] [Abstract][Full Text] [Related]
35. The human islet amyloid polypeptide reduces hippocampal tauopathy and behavioral impairments in P301S mice without inducing neurotoxicity or seeding amyloid aggregation. Yang YY; Ren YT; Jia MY; Bai CY; Liang XT; Gao HL; Zhong ML; Wang T; Guo C Exp Neurol; 2023 Apr; 362():114346. PubMed ID: 36750170 [TBL] [Abstract][Full Text] [Related]
36. Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies. Mewes A; Franke H; Singer D PLoS One; 2012; 7(9):e45017. PubMed ID: 22984603 [TBL] [Abstract][Full Text] [Related]
37. Tau passive immunization inhibits not only tau but also Aβ pathology. Dai CL; Tung YC; Liu F; Gong CX; Iqbal K Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379 [TBL] [Abstract][Full Text] [Related]
38. Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model. Sacher C; Blume T; Beyer L; Peters F; Eckenweber F; Sgobio C; Deussing M; Albert NL; Unterrainer M; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Brzak I; Neumann U; Saito T; Saido TC; Bartenstein P; Rominger A; Herms J; Brendel M J Nucl Med; 2019 Dec; 60(12):1787-1793. PubMed ID: 31302633 [TBL] [Abstract][Full Text] [Related]
39. PPARγ-mediated microglial activation phenotype is involved in depressive-like behaviors and neuroinflammation in stressed C57BL/6J and ob/ob mice. Qin X; Wang W; Wu H; Liu D; Wang R; Xu J; Jiang H; Pan F Psychoneuroendocrinology; 2020 Jul; 117():104674. PubMed ID: 32422516 [TBL] [Abstract][Full Text] [Related]
40. Bis(ethylmaltolato)oxidovanadium (IV) attenuates amyloid-beta-mediated neuroinflammation by inhibiting NF-κB signaling pathway via a PPARγ-dependent mechanism. He Z; Li X; Han S; Ren B; Hu X; Li N; Du X; Ni J; Yang X; Liu Q Metallomics; 2021 Jul; 13(7):. PubMed ID: 34124763 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]